Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Total 13F shares
-
103,476,748
-
Share change
-
+11,640,305
-
Total reported value
-
$842,301,497
-
Put/Call ratio
-
76%
-
Price per share
-
$8.14
-
Number of holders
-
127
-
Value change
-
+$96,426,074
-
Number of buys
-
71
-
Number of sells
-
49
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q2 2022
As of 30 Jun 2022,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,476,748 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, MIC Capital Management UK LLP, BlackRock Inc., VANGUARD GROUP INC, Obvious Management Services, L.L.C., Data Collective IV GP, LLC, Laurion Capital Management LP, NORGES BANK, DCVC Opportunity Fund II GP, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.